Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Intracardiac illuminator offered for licensing

Nov. 28, 1996

Novel vaccine delivery system available for licensing

Nov. 28, 1996

Licenses available for lung function monitor

Nov. 28, 1996

Exclusive worldwide rights offered for peptide-cleaving endopeptidase

Nov. 28, 1996

Potential drug screening invention available for licensing

Nov. 27, 1996

Tularik receives patent coverage relating to drug discovery efforts

Nov. 26, 1996

Cytel/Abbott collaboration reaches milestone

Nov. 22, 1996

Theratechnologies and AEterna sign technology licensing agreement

Nov. 22, 1996

IVAX and Glaxo Wellcome to expand Easi-Breathe agreement

Nov. 21, 1996

LTB4-PPARalpha as a new target for drug design

Nov. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...